These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 4472773

  • 1. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T.
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract] [Full Text] [Related]

  • 2. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB, Friedman E, Gershon S.
    J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
    [No Abstract] [Full Text] [Related]

  • 3. Structure-activity relationships in psychotomimetic phenylalkylamines.
    Aldous FA, Barrass BC, Brewster K, Buxton DA, Green DM, Pinder RM, Rich P, Skeels M, Tutt KJ.
    J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Psychomimetic methylamphetamine derivatives.
    Knoll J, Vizi ES, Ecseri Z.
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):442-51. PubMed ID: 5916746
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D, Palumbo PA, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [Abstract] [Full Text] [Related]

  • 9. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.
    Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA.
    Brain Res; 2004 Oct 08; 1023(1):134-40. PubMed ID: 15364028
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB, Rutledge MA, Carbonaro T, Forster MJ.
    Psychopharmacology (Berl); 2009 Jul 08; 204(4):715-24. PubMed ID: 19288085
    [Abstract] [Full Text] [Related]

  • 11. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB, Hine B, Gershon S.
    Eur J Pharmacol; 1974 Nov 08; 29(1):89-92. PubMed ID: 4435048
    [No Abstract] [Full Text] [Related]

  • 12. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH, Commissaris RL.
    Neurosci Biobehav Rev; 1982 Nov 08; 6(4):521-7. PubMed ID: 6817241
    [Abstract] [Full Text] [Related]

  • 13. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME, Heym J, Jacobs BL.
    Brain Res; 1981 Jun 29; 215(1-2):275-93. PubMed ID: 6114779
    [Abstract] [Full Text] [Related]

  • 14. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA.
    Eur J Pharmacol; 1983 Jan 21; 86(3-4):453-9. PubMed ID: 6572591
    [Abstract] [Full Text] [Related]

  • 15. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE, Pfister WR, Yim GK.
    Life Sci; 1978 Jun 26; 22(24):2165-70. PubMed ID: 672453
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. LSD, psychotogenic procedures, and brain neurohumors.
    Freedman DX.
    Psychopharmacol Bull; 1975 Apr 26; 11(2):42-3. PubMed ID: 237298
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R, Lyness WH, Cordon JJ, Moore KE, Rech RH.
    Pharmacol Biochem Behav; 1980 Nov 26; 13(5):621-6. PubMed ID: 7443731
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.